Report Description
The global chronic disease management market size was valued at nearly USD 12.8 Billion in 2022 and is anticipated to reach USD 18.8 Billion by 2031, expanding at a CAGR of 4.3% during the forecast period, 2023 – 2031. The growth of the market is attributed to the growing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders, rising disposable income, and growing investment on preventive healthcare.
Chronic diseases are classified as those that last one year and above that limit the daily activities of an individual. These diseases require intrinsic and personal medical attention for effective treatment. Chronic diseases care involves an integrated approach to managing illness that includes check-ups, treatment co-ordination, screenings, and educating patients.
Substantial cost reductions are a direct advantage for patients opting for chronic disease management subscriptions with reduced frequency of hospitalizations and intensive care visits. Close to 20% reduction in healthcare expenses has been recorded for patients managed through chronic care management platforms as reported by the American Health Policy Institute. Integration of feedback and report sharing between physicians, patients, and other healthcare service providers is effective through efficient management of patients suffering from chronic illnesses.
The market report finds that the COVID-19 pandemic had a positive impact on the chronic disease management market with the integration of healthcare systems with IT resources. The use of healthcare payer solutions and patient management systems integration increased during the pandemic with reduced manpower.
Chronic Disease Management Market Dynamics
Increasing geriatric population and prevailing chronic diseases such as cancer and heart ailments are driving the market of the chronic disease management market. Integration of IT resources with healthcare systems is expected to drive the chronic disease management market.
Lack of trained workforce with cross-domain functional skills may hamper the market. Upfront expenses for technology integration with existing healthcare systems is likely to restrain the market.
Government-led investments in the research of chronic diseases for the expansion of the promotion of preventive healthcare among the masses is expected to provide the chronic disease management market with opportunities in the coming years.
Scope of Chronic Disease Management Market Report
The market report includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have been included in the report.
Attributes
|
Details
|
Report Title
|
Chronic Disease Management Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
Base Year
|
2022
|
Historic Data
|
2016 – 2021
|
Forecast Period
|
2023–2031
|
Segmentation
|
Type (Services and Solutions), Deployment Mode (On-premise Solution, Cloud-based Solution, and Web-based), Service Type (Implementation Service, Educational Service, Consulting Service, and Others), Disease (Diabetes, Cancer, Asthma, HIV, Chronic Obstructive Pulmonary Disorders, Cardiovascular, Gastro-intestinal, and Others), and End-user (Healthcare Payers, Healthcare Providers, and Others)
|
Regional Scope
|
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
|
Report Coverage
|
Company Share, Chronic Disease Management Market Size and Analysis, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
Key Players Covered in the Report
|
Medecision; Epic Systems Corporation; WellSky; ZeOmega; Health Catalyst; Cedar Gate Technologies; IBM; Phablecare; Altruista Health; TCS Healthcare Technologies; Koninklijke Philips N.V.; Hinduja Global Solutions Ltd.; NXGN Management, LLC; MINES & Associates, Inc.; Casenet, LLC; ExlServings Holdings, Inc.; cliexa, Inc.; ScienceSoft USA Corporation; Vivify Health, Inc.; and Allscripts Healthcare, LLC.
|
Chronic Disease Management Market Segment Insights
Type Segment Analysis
Based on the type, the chronic disease management market is bifurcated into services and solutions. The solutions segment is expected to expand at a significant pace during the projection period, owing to the reduction in exacerbations, complications, and readmissions through the use of chronic care management diagnostics software. Real-time medical data exchange between laboratories and healthcare facilities has reduced the onsite appointments for patients, which is expected to boost the segment.
The services segment is anticipated to hold a key share of the market, owing to the increasing use of self-care services adopted by patients such as self-care monitoring in diabetes care. A decrease in emergency room visits and hospital admissions with the growing use of chronic care management diagnostics services is expected to boost the segment in the forecast period.
Deployment Mode Segment Analysis
On the basis of deployment mode, the market is segmented into on-premise solution, cloud-based solution, and web-based. The cloud-based solution segment is expected to register a considerable CAGR during the forecast period, owing to the stronger emphasis on providing efficient and cost-effective solutions. Increasing research and development activities in several developing countries is expected to boost the segment.
Service Type Segment Analysis
Based on service type, chronic disease management is segregated into implementation service, educational service, consulting service, and others. The implementation service segment is anticipated to register a robust growth rate during the forecast period, due to its flexibility, scalability, and affordability. Increasing adoption of enterprise application software and enhanced processing support is boosting the segment.
Disease Segment Analysis
On the basis of disease, the market is subdivided into diabetes, cancer, asthma, chronic obstructive pulmonary disorders, and others. The diabetes segment is expected to dominate the segment in the forecast period, owing to the growing prevalence of diabetes due to unhealthy lifestyles and consumption of unhealthy food leading to obesity. The rise in type-2 diabetes treatment cases has increased the demand to have disease management systems for effective control of the disease spread and patient care which is likely to bolster the segment in the forecast period.
The cardiovascular segment is expected to expand exponentially in the coming years, due to the rise in physical inactivity and consumption of unhealthy lifestyle changes such as excessive intake of alcohol. Extreme conditions of heart ailments such as arrhythmia, coronary artery diseases, and heart muscle scarring are treatable only in hospitals with chronic disease management facilities, which is anticipated to propel the segment.
End-User Segment Analysis
Based on end-users, the chronic disease management market is divided into healthcare payers, healthcare providers, and others. The healthcare provider segment is projected to hold high revenue shares of the market, owing to rising incidences of long-term illnesses. The treatment for chronic diseases is available only in multispecialty healthcare facilities at competitive costs than private clinics which is expected to drive the segment in the forecast period.
The healthcare payers segment is anticipated to expand at a rapid pace owing to the rising health consciousness and increased expenses on preventive health checkups. Rising numbers of the geriatric population is likely to boost the market in the coming years.
Regional Analysis
In terms of region, the global chronic disease management market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market during the projection period owing to the growing cases of chronic health diseases such as cardiovascular diseases, arthritis, diabetes, and cancer. Growing number of geriatric populations with chronic health conditions is expected to drive the market in North America.
The market of Asia Pacific is projected to grow at a rapid pace in the coming years, owing to the rising population and the limited healthcare resources available in treating chronic and complex illnesses. Growing political focus on improving existing healthcare facilities such as public hospitals is likely to propel the market in Asia Pacific.
Segments
The global chronic disease management market has been segmented on the basis of
Type
Deployment Mode
- On-premise Solution
- Cloud-based Solution
- Web-based
Service Type
- Implementation Service
- Educational Service
- Consulting Service
- Others
Disease
- Diabetes
- Cancer
- Asthma
- HIV
- Chronic Obstructive Pulmonary Disorders
- Cardiovascular
- Gastro-intestinal
- Others
End-user
- Healthcare Payers
- Healthcare Providers
- Others
Region
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Medecision
- Epic Systems Corporation
- WellSky
- ZeOmega
- Health Catalyst
- Cedar Gate Technologies
- IBM
- Phablecare
- Altruista Health
- TCS Healthcare Technologies
- Koninklijke Philips N.V.
- Hinduja Global Solutions Ltd.
- NXGN Management, LLC
- MINES & Associates, Inc.
- Casenet, LLC
- ExlServings Holdings, Inc.
- cliexa, Inc.
- ScienceSoft USA Corporation
- Vivify Health, Inc.
- Allscripts Healthcare, LLC
Competitive Landscape
Key players competing in the chronic disease management market are Medecision; Epic Systems Corporation; WellSky; ZeOmega; Health Catalyst; Cedar Gate Technologies; IBM; Phablecare; Altruista Health; TCS Healthcare Technologies; Koninklijke Philips N.V.; Hinduja Global Solutions Ltd.; NXGN Management, LLC; MINES & Associates, Inc.; Casenet, LLC; ExlService Holdings, Inc.; cliexa, Inc.; ScienceSoft USA Corporation; Vivify Health, Inc.; and Allscripts Healthcare, LLC
These companies adopted development strategies including mergers, acquisitions, partnerships, collaboration, product launches, and production expansion to increase their consumer base worldwide.
- On June 21, 2023, ZeOmega partnered with HealPros, a healthcare company that works with the largest health plans to build and deliver programs that changes the lives of people with chronic illness. This partnership has significant results for its members by helping them access personalized care and delivering in-home experiences people love.
- On January 9, 2023, WellSky partnered with Panoramic Health to deliver high-quality, more cost-effective care to patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD).
- In March 2022, Phablecare, a chronic disease management company acquired Fused Training for expanding and strengthening its Type1 diabetes health service offering.
Table Of Content
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Chronic Disease Management Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Chronic Disease Management Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Chronic Disease Management Market - Supply Chain
4.5. Global Chronic Disease Management Market Forecast
4.5.1. Chronic Disease Management Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Chronic Disease Management Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Chronic Disease Management Market Absolute $ Opportunity
5. Global Chronic Disease Management Market Analysis and Forecast by Types
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Types
5.2.2. Y-o-Y Growth Projections by Types
5.3. Chronic Disease Management Market Size and Volume Forecast by Types
5.3.1. Services
5.3.2.
Solutions
5.4. Absolute $ Opportunity Assessment by Types
5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Chronic Disease Management Market Analysis and Forecast by End Users
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by End Users
6.2.2. Y-o-Y Growth Projections by End Users
6.3. Chronic Disease Management Market Size and Volume Forecast by End Users
6.3.1. Healthcare Payers
6.3.2.
Healthcare Providers
6.3.3.
Others
6.4. Absolute $ Opportunity Assessment by End Users
6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Chronic Disease Management Market Analysis and Forecast by Region
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Region
7.2.2. Y-o-Y Growth Projections by Region
7.3. Chronic Disease Management Market Size and Volume Forecast by Region
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa (MEA)
7.4. Absolute $ Opportunity Assessment by Region
7.5. Market Attractiveness/Growth Potential Analysis by Region
7.6. Global Chronic Disease Management Demand Share Forecast, 2019-2026
8. North America Chronic Disease Management Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.2. North America Chronic Disease Management Market Size and Volume Forecast by Country
8.2.1. U.S.
8.2.2. Canada
8.3. Absolute $ Opportunity Assessment by Country
8.4. North America Chronic Disease Management Market Size and Volume Forecast by Types
8.4.1. Services
8.4.2.
Solutions
8.5. Basis Point Share (BPS) Analysis by Types
8.6. Y-o-Y Growth Projections by Types
8.7. North America Chronic Disease Management Market Size and Volume Forecast by End Users
8.7.1. Healthcare Payers
8.7.2.
Healthcare Providers
8.7.3.
Others
8.8. Basis Point Share (BPS) Analysis by End Users
8.9. Y-o-Y Growth Projections by End Users
8.10. Market Attractiveness/Growth Potential Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By Application
8.11. North America Chronic Disease Management Demand Share Forecast, 2019-2026
9. Latin America Chronic Disease Management Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Latin America Average Pricing Analysis
9.2. Latin America Chronic Disease Management Market Size and Volume Forecast by Country
9.2.1. Brazil
9.2.2. Mexico
9.2.3. Rest of Latin America
9.3. Absolute $ Opportunity Assessment by Country
9.4. Latin America Chronic Disease Management Market Size and Volume Forecast by Types
9.4.1. Services
9.4.2.
Solutions
9.5. Basis Point Share (BPS) Analysis by Types
9.6. Y-o-Y Growth Projections by Types
9.7. Latin America Chronic Disease Management Market Size and Volume Forecast by End Users
9.7.1. Healthcare Payers
9.7.2.
Healthcare Providers
9.7.3.
Others
9.8. Basis Point Share (BPS) Analysis by End Users
9.9. Y-o-Y Growth Projections by End Users
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.11. Latin America Chronic Disease Management Demand Share Forecast, 2019-2026
10. Europe Chronic Disease Management Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Europe Average Pricing Analysis
10.2. Europe Chronic Disease Management Market Size and Volume Forecast by Country
10.2.1. Germany
10.2.2. France
10.2.3. Italy
10.2.4. U.K.
10.2.5. Spain
10.2.6. Russia
10.2.7. Rest of Europe
10.3. Absolute $ Opportunity Assessment by Country
10.4. Europe Chronic Disease Management Market Size and Volume Forecast by Types
10.4.1. Services
10.4.2.
Solutions
10.5. Basis Point Share (BPS) Analysis by Types
10.6. Y-o-Y Growth Projections by Types
10.7. Europe Chronic Disease Management Market Size and Volume Forecast by End Users
10.7.1. Healthcare Payers
10.7.2.
Healthcare Providers
10.7.3.
Others
10.8. Basis Point Share (BPS) Analysis by End Users
10.9. Y-o-Y Growth Projections by End Users
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.11. Europe Chronic Disease Management Demand Share Forecast, 2019-2026
11. Asia Pacific Chronic Disease Management Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Asia Pacific Average Pricing Analysis
11.2. Asia Pacific Chronic Disease Management Market Size and Volume Forecast by Country
11.2.1. China
11.2.2. Japan
11.2.3. South Korea
11.2.4. India
11.2.5. Australia
11.2.6. Rest of Asia Pacific (APAC)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Asia Pacific Chronic Disease Management Market Size and Volume Forecast by Types
11.4.1. Services
11.4.2.
Solutions
11.5. Basis Point Share (BPS) Analysis by Types
11.6. Y-o-Y Growth Projections by Types
11.7. Asia Pacific Chronic Disease Management Market Size and Volume Forecast by End Users
11.7.1. Healthcare Payers
11.7.2.
Healthcare Providers
11.7.3.
Others
11.8. Basis Point Share (BPS) Analysis by End Users
11.9. Y-o-Y Growth Projections by End Users
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.11. Asia Pacific Chronic Disease Management Demand Share Forecast, 2019-2026
12. Middle East & Africa Chronic Disease Management Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Middle East & Africa Average Pricing Analysis
12.2. Middle East & Africa Chronic Disease Management Market Size and Volume Forecast by Country
12.2.1. Saudi Arabia
12.2.2. South Africa
12.2.3. UAE
12.2.4. Rest of Middle East & Africa (MEA)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Middle East & Africa Chronic Disease Management Market Size and Volume Forecast by Types
12.4.1. Services
12.4.2.
Solutions
12.5. Basis Point Share (BPS) Analysis by Types
12.6. Y-o-Y Growth Projections by Types
12.7. Middle East & Africa Chronic Disease Management Market Size and Volume Forecast by End Users
12.7.1. Healthcare Payers
12.7.2.
Healthcare Providers
12.7.3.
Others
12.8. Basis Point Share (BPS) Analysis by End Users
12.9. Y-o-Y Growth Projections by End Users
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.11. Middle East & Africa Chronic Disease Management Demand Share Forecast, 2019-2026
13. Competition Landscape
13.1. Global Chronic Disease Management Market: Market Share Analysis
13.2. Chronic Disease Management Distributors and Customers
13.3. Chronic Disease Management Market: Competitive Dashboard
13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
13.4.1. Medecision
13.4.2.
Epic Systems Corporation
13.4.3.
WellSky
13.4.4.
ZeOmega
13.4.5.
Health Catalyst
13.4.6.
Cedar Gate Technologies
13.4.7.
IBM
13.4.8.
Phablecare
13.4.9.
Altruista Health
13.4.10.
TCS Healthcare Technologies
13.4.11.
Koninklijke Philips N.V.
13.4.12.
Hinduja Global Solutions Ltd.
13.4.13.
NXGN Management, LLC
13.4.14.
MINES & Associates, Inc.
13.4.15.
Casenet, LLC
13.4.16.
ExlServings Holdings, Inc.
13.4.17.
cliexa, Inc.
13.4.18.
ScienceSoft USA Corporation
13.4.19.
Vivify Health, Inc.
13.4.20.
Allscripts Healthcare, LLC